Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06651600 in adults and adolescents with alopecia areata and at least 50% scalp hair loss
2018-001714-14Phase 2Unknown
- Sponsor
- Pfizer
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alopecia areata comparing PF-06651600 dose-ranging arms with Placebo (2 arms). Primary endpoint: Absolute SALT score response at Week 24. Status: unknown.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on 2018-001714-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001714-14.